333 related articles for article (PubMed ID: 28379944)
1. Structural basis for selectivity and diversity in angiotensin II receptors.
Zhang H; Han GW; Batyuk A; Ishchenko A; White KL; Patel N; Sadybekov A; Zamlynny B; Rudd MT; Hollenstein K; Tolstikova A; White TA; Hunter MS; Weierstall U; Liu W; Babaoglu K; Moore EL; Katz RD; Shipman JM; Garcia-Calvo M; Sharma S; Sheth P; Soisson SM; Stevens RC; Katritch V; Cherezov V
Nature; 2017 Apr; 544(7650):327-332. PubMed ID: 28379944
[TBL] [Abstract][Full Text] [Related]
2. Electronic sculpting of ligand-GPCR subtype selectivity: the case of angiotensin II.
Magnani F; Pappas CG; Crook T; Magafa V; Cordopatis P; Ishiguro S; Ohta N; Selent J; Bosnyak S; Jones ES; Gerothanassis IP; Tamura M; Widdop RE; Tzakos AG
ACS Chem Biol; 2014 Jul; 9(7):1420-5. PubMed ID: 24787922
[TBL] [Abstract][Full Text] [Related]
3. Interplay between intracellular loop 1 and helix VIII of the angiotensin II type 2 receptor controls its activation.
Connolly A; Holleran BJ; Simard É; Baillargeon JP; Lavigne P; Leduc R
Biochem Pharmacol; 2019 Oct; 168():330-338. PubMed ID: 31348898
[TBL] [Abstract][Full Text] [Related]
4. Structural determinants of subtype selectivity and functional activity of angiotensin II receptors.
Sallander J; Wallinder C; Hallberg A; Åqvist J; Gutiérrez-de-Terán H
Bioorg Med Chem Lett; 2016 Feb; 26(4):1355-9. PubMed ID: 26810314
[TBL] [Abstract][Full Text] [Related]
5. Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors.
Bosnyak S; Jones ES; Christopoulos A; Aguilar MI; Thomas WG; Widdop RE
Clin Sci (Lond); 2011 Oct; 121(7):297-303. PubMed ID: 21542804
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of the human angiotensin II type 2 receptor bound to an angiotensin II analog.
Asada H; Horita S; Hirata K; Shiroishi M; Shiimura Y; Iwanari H; Hamakubo T; Shimamura T; Nomura N; Kusano-Arai O; Uemura T; Suno C; Kobayashi T; Iwata S
Nat Struct Mol Biol; 2018 Jul; 25(7):570-576. PubMed ID: 29967536
[TBL] [Abstract][Full Text] [Related]
7. The Crystal Structure of Angiotensin II Type 2 Receptor with Endogenous Peptide Hormone.
Asada H; Inoue A; Ngako Kadji FM; Hirata K; Shiimura Y; Im D; Shimamura T; Nomura N; Iwanari H; Hamakubo T; Kusano-Arai O; Hisano H; Uemura T; Suno C; Aoki J; Iwata S
Structure; 2020 Apr; 28(4):418-425.e4. PubMed ID: 31899086
[TBL] [Abstract][Full Text] [Related]
8. The Other Angiotensin II Receptor: AT
Juillerat-Jeanneret L
J Med Chem; 2020 Mar; 63(5):1978-1995. PubMed ID: 32030982
[TBL] [Abstract][Full Text] [Related]
9. Evolution of Angiotensin Peptides and Peptidomimetics as Angiotensin II Receptor Type 2 (AT2) Receptor Agonists.
Vasile S; Hallberg A; Sallander J; Hallberg M; Åqvist J; Gutiérrez-de-Terán H
Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32340100
[TBL] [Abstract][Full Text] [Related]
10. Update on Angiotensin II Subtype 2 Receptor: Focus on Peptide and Nonpeptide Agonists.
Ranjit A; Khajehpour S; Aghazadeh-Habashi A
Mol Pharmacol; 2021 Jun; 99(6):469-487. PubMed ID: 33795351
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of ligand-induced activation of angiotensin II type 1 receptor signaling by the type 2 receptor via protein kinase C.
Inuzuka T; Fujioka Y; Tsuda M; Fujioka M; Satoh AO; Horiuchi K; Nishide S; Nanbo A; Tanaka S; Ohba Y
Sci Rep; 2016 Feb; 6():21613. PubMed ID: 26857745
[TBL] [Abstract][Full Text] [Related]
12. Emerging concepts of regulation of angiotensin II receptors: new players and targets for traditional receptors.
Mogi M; Iwai M; Horiuchi M
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2532-9. PubMed ID: 17717300
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension.
Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC
J Hypertens; 2010 Jan; 28(1):111-8. PubMed ID: 19797979
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II type 2 receptor (AT2R) in renal and cardiovascular disease.
Chow BS; Allen TJ
Clin Sci (Lond); 2016 Aug; 130(15):1307-26. PubMed ID: 27358027
[TBL] [Abstract][Full Text] [Related]
15. Development of CoMFA models of affinity and selectivity to angiotensin II type-1 and type-2 receptors.
Sköld C; Karlén A
J Mol Graph Model; 2007 Jul; 26(1):145-53. PubMed ID: 17161636
[TBL] [Abstract][Full Text] [Related]
16. Computational approaches on angiotensin receptors and their ligands: recent developments and results.
Tuccinardi T; Martinelli A
Curr Med Chem; 2007; 14(29):3105-21. PubMed ID: 18220745
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
[TBL] [Abstract][Full Text] [Related]
18. Adrenal angiotensin II type 1 receptor biased signaling: The case for "biased" inverse agonism for effective aldosterone suppression.
Ferraino KE; Cora N; Pollard CM; Sizova A; Maning J; Lymperopoulos A
Cell Signal; 2021 Jun; 82():109967. PubMed ID: 33640432
[TBL] [Abstract][Full Text] [Related]
19. β-Pro7Ang III is a novel highly selective angiotensin II type 2 receptor (AT2R) agonist, which acts as a vasodepressor agent via the AT2R in conscious spontaneously hypertensive rats.
Del Borgo M; Wang Y; Bosnyak S; Khan M; Walters P; Spizzo I; Perlmutter P; Hilliard L; Denton K; Aguilar MI; Widdop RE; Jones ES
Clin Sci (Lond); 2015 Sep; 129(6):505-13. PubMed ID: 26186568
[TBL] [Abstract][Full Text] [Related]
20. Essential role of angiotensin receptors in the modulation of intestinal epithelial cell apoptosis.
Wang W; Sun L; Xiao W; Yang H
J Pediatr Gastroenterol Nutr; 2013 Nov; 57(5):562-9. PubMed ID: 23783021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
